As of September 2024, Pharmosa Biopharm has a market cap of $234.41M. This makes Pharmosa Biopharm the world's 16414th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $403.46M | 25.57% |
2023 | $321.31M | 4682.61% |
2022 | $6.72M | -12.38% |
2021 | $7.67M | 32.91% |
2020 | $5.77M | 17.04% |
2019 | $4.93M | 35.00% |
2018 | $3.65M | -14.68% |
2017 | $4.28M | 10.05% |
2016 | $3.89M | 91.55% |
2015 | $2.03M | 11.20% |
2014 | $1.83M | -27.54% |
2013 | $2.52M | 2.99% |
2012 | $2.45M | - |